Tags: lung cancer

4/17/2018

Immunotherapy prolongs survival, but at what cost? Washington Post needed more on treatment downsides

4/17/2018

Without any independent sources providing insight, readers of TIME’s coverage on lung cancer immunotherapy mostly left in the dark

3/27/2018

Reuters lets Roche make data-free claims about drug’s impact on lung cancer survival

11/29/2016

NPR story says older patients ‘can benefit’ from lung cancer surgery, but study didn’t show that

2 5/21/2015

Post coverage of new lung cancer test misses on caveats, costs, and harms

3 5/13/2015

The Times offers informative breakdown on the value of lung cancer screening

1/15/2015

New drug Opdivo successfully ends lung cancer trial

1 4/15/2013

Freezing Treatment May Help Destroy Lung Tumors: Study

3/26/2013

Women who ate more soy survive lung cancer better, study finds

8/17/2011

Dogs Sniff Out Lung Cancer in Humans

Story Reviews

Systematic, Criteria-Driven

@HealthNewsRevu

HealthNewsReview.org @healthnewsrevu ·

The tale of two “negative” studies. Or, how spin is applied to make research findings look more impressive. A must read. https://johnmandrola.substack.com/p/the-tale-of-two-negative-studies

Reply on Twitter 1541491162799800323 Retweet on Twitter 1541491162799800323 1 Like on Twitter 1541491162799800323 2 Twitter 1541491162799800323

Retweet on Twitter HealthNewsReview.org Retweeted

Carolyn Thomas ☮️ @heartsisters ·

The @nytimes chose to interview one of the editors of the @AnnalsofIM (publisher of this paper) who "gushed with extraordinary glee: It’s huge! There are very few things that reduce your mortality by 30%."
Turns out coffee is not one of those few things despite all that glee. https://twitter.com/garyschwitzer/status/1533202075928215558

Reply on Twitter 1539728971138338816 Retweet on Twitter 1539728971138338816 1 Like on Twitter 1539728971138338816 5 Twitter 1539728971138338816